These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3387316)

  • 1. [The results of treating patients with endogenous bronchial asthma with TFX].
    Moniuszko T; Szymański W; Chyrek-Borowska S
    Pol Tyg Lek; 1988 Jan 18-25; 43(3-4):111-3. PubMed ID: 3387316
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of vilozen on the immune status of bronchial asthma patients].
    Kogosova LS; Kovalenko NN; Strafun OV; Markov AE
    Vrach Delo; 1990 Oct; (10):48-50. PubMed ID: 2080579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical trial of treatment with the preparation TFX "Polfa" of 4 patients with acquired immunologic deficiency syndromes].
    Romański B; Montowska L; Zbikowska-Götz M; Staszyńska M
    Pol Tyg Lek; 1985 Oct 7-14; 40(40-41):1139-42. PubMed ID: 3911181
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical trial of immunoregulation using the TFX Polfa preparation in non-Hodgkin's lymphoma].
    Górski J; Kicińska M; Gawrecka G
    Przegl Lek; 1988; 45(7):555-8. PubMed ID: 3070639
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experience with the use of vilozen in patients with bronchial asthma].
    Ialkut SI; Kotova SA
    Ter Arkh; 1989; 61(8):55-7. PubMed ID: 2588167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Principles of immunocorrective therapy using the thymus preparation T-activin].
    Arion VIa; Ivanushkin EF
    Khirurgiia (Mosk); 1984 Nov; (11):44-8. PubMed ID: 6335205
    [No Abstract]   [Full Text] [Related]  

  • 7. [Stage-by-stage complex immunologic correction in patients with bronchial asthma living in a large industrial and power plant region].
    Grigor'ev MA; Mikhaĭlenko AA; Mel'kova TP
    Gig Tr Prof Zabol; 1989; (4):25-7. PubMed ID: 2744567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trials of thymus extract TFX administration in dermatological patients resistant to conventional treatment methods.
    Turowski G; Sanokowska E; Dynowska D
    Mater Med Pol; 1988; 20(2):128-31. PubMed ID: 3065582
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinico-immunologic heterogeneity in patients with bronchial asthma].
    Fedoseev GB; Zhikharev SS; Uslontsev BM; Kozhemiakin AL; Morozov VG
    Klin Med (Mosk); 1987 Dec; 65(12):29-34. PubMed ID: 3502161
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of levamisole on the course of endogenous bronchial asthma].
    Rogala B; Rogala E; Huzarski J
    Pneumonol Pol; 1982 Oct; 50(10):513-8. PubMed ID: 7170185
    [No Abstract]   [Full Text] [Related]  

  • 11. [Theoretical and practical aspects of the clinical use of immunotherapy substituting for thymus functions in man].
    Dabrowski MP; Dabrowska-Bernstein BK; Brzosko WJ
    Pol Tyg Lek; 1983 Mar; 38(13):385-7. PubMed ID: 6605524
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic effectiveness of the immuno stimulating extract of the calf thymus (TFX-Polfa) in cases of acute dermatomyositis].
    Stasiak A; Dudkiéwicz H; Dabrowski M; Dabrowska B; Wasowska B; Brzosko W
    Pol Tyg Lek; 1983 Mar; 38(13):389-92. PubMed ID: 6605525
    [No Abstract]   [Full Text] [Related]  

  • 13. [Typical immune system responses to differential monotherapy with immune-correcting drugs].
    Zemskov AM; Zemskov BM; Zoloedov VI; Lutskii MA
    Fiziol Cheloveka; 2001; 27(4):97-103. PubMed ID: 11573419
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparison of the efficacy of topical and subcutaneous administration of tactivin for correcting secondary immunodeficiencies of young children].
    Arion VIa; Bekman EM; Tiurin NA; Mazurina NA; Filimonova AV
    Biull Eksp Biol Med; 1994 Nov; 118(11):496-8. PubMed ID: 7888649
    [No Abstract]   [Full Text] [Related]  

  • 15. [Secondary immunodeficiency and its correction with thymus preparations in patients with postabortion endometritis].
    Franchuk AE; Benzar ZT
    Akush Ginekol (Mosk); 1990 Sep; (9):40-3. PubMed ID: 2278306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic efficacy of mildronate in pulmonary diseases].
    Mkrtchian VP; Orlov VA
    Lik Sprava; 2005 Dec; (8):72-3. PubMed ID: 16498789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Calf thymus extract (TFX-Polfa) in the treatment of pollinosis. Clinical trials by the double-blind method using a placebo].
    Kowalski ML; Kuna P; Grzegorczyk J; Rozniecki J
    Pol Tyg Lek; 1987 Jun; 42(24):739-42. PubMed ID: 3313315
    [No Abstract]   [Full Text] [Related]  

  • 18. [The possibility of the restoration of interferon formation by biologically active thymus factors in experimentally induced immunodepression].
    Chernenko OD; Grinevich IuA
    Vopr Virusol; 1991; 36(4):309-10. PubMed ID: 1724585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunotherapy of breast cancer patients].
    Korolev VI; Bendiug GD; Dziubko NiA ; Ponomarev IN; Krivorotov AA
    Vrach Delo; 1987 Jun; (6):90-3. PubMed ID: 3630094
    [No Abstract]   [Full Text] [Related]  

  • 20. Initial observations on the administration of thymus extract (TFX) in patients with alimentary tract neoplasms.
    Cybulski L; Turowski G; Politowski M; Urban A; Turaszwili T; Zubel M
    Pol Med Sci Hist Bull (1973); 1976; 15(1):47-9. PubMed ID: 995755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.